State-Level Action on Preemptive Prescribing

Entities in multiple states are taking action against the preemptive prescription of medications for a potential future COVID-19 illness. The North Carolina Medical Board has published a message for all licensees reminding them of the risks of preemptive prescribing, and the Virginia Department of Health has published a recommendation against the practice.

News & Knowledge
All Curi recommendations are based on current CDC criteria at the time of publication. CDC guidance for SARS-CoV-2 infection may, or may not, be adopted by state and local health departments to respond to rapidly changing local circumstances. Providers should always check with their local health department to see if the CDC’s guidance on any given topic has been modified (particularly if more restrictive) from the CDC’s recommended guidelines. Follow this link https://www.cdc.gov/publichealthgateway/healthdirectories/index.html for contact information to your state/local health department. If local recommendations vary from those of the CDC, and you are unsure what recommendations to follow, then it is safer to follow the more restrictive guidelines/recommendations.